On natural and artificial vaccinations

被引:239
作者
Zinkernagel, RM [1 ]
机构
[1] Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland
关键词
immunological memory; immunity; maternal antibodies; autoimmunity; infections; virus; tumors;
D O I
10.1146/annurev.immunol.21.120601.141045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review summarizes the general parameters of cell- and antibody-mediated immune protection and the basic mechanisms responsible for what we call immunological memory. From this basis, the various successes and difficulties of vaccines are evaluated with respect to the role of antigen in maintaining protective immunity. Based on the fact that in humans during the first 12-48 months maternal antibodies from milk and serum protect against classical acute childhood and other infections, the concept is developed that maternal antibodies attenuate most infections of babies and infants and turn them into effective vaccines. If this "natural vaccination" under passive protective conditions does not occur, acute childhood diseases may be severe, unless infants are actively vaccinated with conventional vaccines early enough, i.e., in synchronization with the immune system's maturation. Although vaccines are available against the classical childhood diseases, they are not available for many seemingly milder childhood infections such as gastrointestinal and respiratory infections; these may eventually trigger immunopathological diseases. These changing balances between humans and infections caused by changes in nursing habits but also in hygiene levels may well be involved in changing disease patterns including increased frequencies of certain autoimmune and degenerative diseases.
引用
收藏
页码:515 / 546
页数:32
相关论文
共 135 条
[101]   The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response [J].
Rehermann, B ;
Ferrari, C ;
Pasquinelli, C ;
Chisari, FV .
NATURE MEDICINE, 1996, 2 (10) :1104-1108
[102]   DNA vaccines for viral infections: Basic studies and applications [J].
Robinson, HL ;
Pertmer, TM .
ADVANCES IN VIRUS RESEARCH, VOL 55, 2000, 55 :1-74
[103]   ANALYSIS OF THE KINETICS OF ANTIVIRAL MEMORY T-HELP INVIVO - CHARACTERIZATION OF SHORT-LIVED CROSS-REACTIVE T-HELP [J].
ROOST, HP ;
CHARAN, S ;
ZINKERNAGEL, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (12) :2547-2554
[104]   EARLY HIGH-AFFINITY NEUTRALIZING ANTIVIRAL IGG RESPONSES WITHOUT FURTHER OVERALL IMPROVEMENTS OF AFFINITY [J].
ROOST, HP ;
BACHMANN, MF ;
HAAG, A ;
KALINKE, U ;
PLISKA, V ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1257-1261
[105]   Vigorous HIV-1-specific CD4(+) T cell responses associated with control of viremia [J].
Rosenberg, ES ;
Billingsley, JM ;
Caliendo, AM ;
Boswell, SL ;
Sax, PE ;
Kalams, SA ;
Walker, BD .
SCIENCE, 1997, 278 (5342) :1447-1450
[106]   Live attenuated AIDS viruses as vaccines: promise or peril? [J].
Ruprecht, RM .
IMMUNOLOGICAL REVIEWS, 1999, 170 :135-149
[108]   SUCCESSFUL IMMUNIZATION OF CHILDREN WITH AND WITHOUT MATERNAL ANTIBODY BY AEROSOLIZED MEASLES-VACCINE .1. DIFFERENT RESULTS WITH UNDILUTED HUMAN-DIPLOID CELL AND CHICK-EMBRYO FIBROBLAST VACCINES [J].
SABIN, AB ;
ARECHIGA, AF ;
DECASTRO, JF ;
SEVER, JL ;
MADDEN, DL ;
SHEKARCHI, I ;
ALBRECHT, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (19) :2651-2662
[109]   MATERNAL ANTIBODIES PARTLY INHIBIT AN ACTIVE ANTIBODY-RESPONSE TO ROUTINE TETANUS TOXOID IMMUNIZATION IN INFANTS [J].
SARVAS, H ;
KURIKKA, S ;
SEPPALA, IJT ;
MAKELA, PH ;
MAKELA, O .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (05) :977-979
[110]  
Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO